ORMP · Oramed Pharmaceuticals Inc. · Executive Compensation

$4.66 -0.10 (-2.10%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$193.84M

41.60M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Nadav Kidron	President and CEO and director	$439,076	$220,582	—	$569,062	—	$539,131	$1,767,851
Miriam Kidron	Chief Scientific Officer and director	$305,840	$70,000	—	$299,506	—	$13,354	$688,700
Joshua Hexter	Chief Operating & Business Officer	$190,801	$12,169	—	$351,128	—	$54,735	$608,833
Avraham Gabay	Chief Financial Officer	$130,554	$15,591	—	—	—	$44,912	$191,418

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Nadav Kidron	President and CEO and director	$419,460	$224,975	—	$398,910	—	$507,750	$1,551,095
Miriam Kidron	Chief Scientific Officer and director	$267,386	$123,149	—	$211,128	—	$14,503	$616,166
Hilla Eisenberg	Chief Financial Officer	$80,145	$23,859	—	$75,113	—	$11,669	$190,786
Mark Hasleton	VP Business Development	$114,118	—	—	$45,677	—	$18,949	$178,745
Avraham Gabay	Chief Financial Officer	$32,122	—	—	$73,928	—	$9,441	$115,491
Joshua Hexter	Chief Operating & Business Officer	$52,848	—	—	—	—	$9,022	$61,870

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Nadav Kidron	President and CEO and director	$436,310	$148,795	—	$522,569	—	$442,326	$1,550,000
Miriam Kidron	Chief Scientific Officer and director	$273,595	$46,614	—	$253,204	—	$13,643	$587,056
Joshua Hexter	Chief Operating & Business Officer	$161,002	$26,895	—	$269,196	—	$50,505	$507,598
Hilla Eisenberg	Chief Financial Officer	$140,518	$9,985	—	$80,810	—	$26,099	$257,412

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Miriam Kidron	Chief Scientific Officer and director	$254,765	$50,000	$581,932	$359,224	—	$12,775	$1,258,696
Nadav Kidron	President and Chief Executive Officer and director	$399,804	$123,000	—	$585,150	—	$45,579	$1,153,533
Hilla Eisenberg	Chief Financial Officer	$87,045	—	—	$112,978	—	$16,133	$200,023

Executive changes

Person	Role	Change	Effective	Filed
Leonard Sank	Board	Resigned	2026-01-01	2025-12-31

Key facts CIK 1176309 CUSIP 68403P203 13F (30d) 26 filings 26 filers Visit website Investor relations